Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
09/2014
09/12/2014WO2014135107A1 Novel nucleoside phosphoramidate compound and use thereof
09/12/2014WO2014134750A1 2,6,9-trisubstituted purine derivative and preparation method and use thereof
09/12/2014WO2014134731A1 Antimicrobial-antibiofilm compositions and methods of use thereof
09/12/2014WO2014134709A1 Topical use of an antimicrobial formulation
09/12/2014WO2014134701A1 Antimicrobial-antibiofilm compositions and methods of use thereof
09/12/2014WO2014134698A1 Cpg oligonucleotide formulations and methods and uses thereof
09/11/2014US20140255497 Organic Compounds
09/11/2014US20140255493 Extrudate and methods of using said extrudate
09/11/2014DE102013003756A1 Piroxicam zur prophylaktischen und therapeutischen Behandlung von CMV-Infektionen Piroxicam for the prophylactic and therapeutic treatment of CMV infections
09/10/2014EP2774932A1 Novel compound contained in manuka honey and use of same
09/10/2014EP2774928A1 Polycyclic pyridone derivative having integrase-inhibiting activity
09/10/2014EP2774927A1 Inhibitors of HCV NS5A
09/10/2014EP2773759A1 Aptamers
09/10/2014EP2773640A1 Bicyclic piperazine compounds
09/10/2014EP2773636A1 Optically active fluconazole analogues containing thiophenes as antifungal agents
09/10/2014EP2773634A1 Rod -like hepatitis c virus inhibitors containing the fragement {2- [4- (bi phenyl - 4 - yl) - 1h - imidazo - 2 - yl]pyrrolidine - 1 - carbonlymethyl} amine
09/10/2014EP2773613A1 Substituted benzylamine compounds, their use in medicine, and in particular the treatment of hepatitis c virus (hcv) infection
09/10/2014EP2773369A1 Compositions and methods for preventing and treating oral diseases
09/09/2014US8829264 Methods and compositions for RNA interference
09/09/2014US8828982 Pyrimidine derivatives for the prevention of HIV infection
09/09/2014US8828933 Mutant tat proteins and uses thereof
09/09/2014US8828932 Bifunctional molecules for inactivating HIV and blocking HIV entry
09/09/2014US8828929 Cytotoxic T cell epitope peptide for SARS coronavirus, and use thereof
09/09/2014US8828413 Peptoid oligomers, pharmaceutical compositions and methods of using the same
09/09/2014US8828405 Method to enhance an immune response of nucleic acid vaccination
09/09/2014US8828375 Expansion of haemopoietic precursors
09/09/2014CA2789415C Macrolides
09/09/2014CA2782927C Derivatives of novel peroxides, method of preparation thereof and use thereof in human medicine as well as in cosmetics for the treatment or prevention of acne
09/09/2014CA2660324C Plasmids with immunological action
09/09/2014CA2616592C Zalcitabine (ddc) boosted lamivudine (3tc) compositions for antiretroviral therapy
09/09/2014CA2461140C Inactivation of papillomavirus
09/04/2014WO2014134297A1 Covalent attachment of bacteriophages to polymeric surfaces
09/04/2014WO2014134251A1 Pharmaceutical compositions
09/04/2014WO2014133323A1 Novel bacteriophage and antibacterial composition comprising the same
09/04/2014WO2014133322A1 Novel bacteriophage and antibacterial composition comprising the same
09/04/2014WO2014133301A1 Novel bacteriophage and antibacterial composition comprising the same
09/04/2014WO2014133290A1 Novel bacteriophage and antibacterial composition comprising the same
09/04/2014WO2014133289A1 Novel bacteriophage and antibacterial composition comprising the same
09/04/2014WO2014133197A1 Flagellar and needle complex (injectosome) loop as anti bacterial drug target
09/04/2014WO2014132267A1 1-substituted, 4-(substituted phenoxymethyl)-1,2,3-triazole compounds with antifungal properties and methods for preparation thereof
09/04/2014WO2014131847A1 Sulfamoyl-arylamides and the use thereof as medicaments for the treatment of hepatitis b
09/04/2014WO2014131315A1 Bridged ring compounds as hepatitis c virus inhibitors, pharmaceutical compositions and uses thereof
09/04/2014WO2014108497A3 Vaccine composition comprising e. coli positive for f18 fimbria and/or f4 fimbria
09/04/2014WO2014074535A9 Flavivirus envelope protein mutations affecting virion disassembly
09/04/2014US20140248700 Method of Differentiation of Morula or Inner Cell Mass Cells and Method of Making Lineage-Defective Embryonic Stem Cells
09/04/2014US20140248661 Zcytor19 polynucleotides, polypeptides, antibodies and methods of use
09/03/2014EP2772544A1 Novel compound and method for producing same
09/03/2014EP2772480A1 Hiv replication inhibitor
09/03/2014EP2772267A2 Immunogenic compositions and methods
09/03/2014EP2772248A1 Pharmaceutical composition and kit for treating bacterial infections
09/03/2014EP2771466A1 Inhibition of viral gene expression
09/03/2014EP2771366A1 Vaccines and methods for creating a vaccine for inducing immunity to all dengue virus serotypes
09/03/2014EP2771356A1 Chimeric molecule involving oligomerized fasl extracellular domain
09/03/2014EP2771338A2 1, 2, 4 - oxadiazole derivatives as ethr inhibitors for use in the treatment tuberculosis
09/03/2014EP2771332A1 Hiv protease inhibitors
09/03/2014EP2771324A1 Myxovirus therapeutics, compounds, and uses related thereto
09/03/2014EP2771316A1 Compounds for the treatment of influenza
09/03/2014EP2771016A1 Primycin and components thereof for use in the treatment or prevention of infections caused by specific pathogens
09/03/2014EP2771013A1 Topical pharmaceutical compositions comprising acyclovir
09/03/2014EP2770993A2 Method of treating hcv infection with a small molecule chk2 inhibitor
09/02/2014US8822637 Somatostatin analogues
09/02/2014US8822530 Sulfur derivatives as chemokine receptor modulators
09/02/2014US8822430 Antiviral compounds
09/02/2014US8822169 HMG1 antibody for treating inflammatory conditions
09/02/2014US8821916 Medical dressing comprising an antimicrobial silver compound
09/02/2014US8821895 Streptococcus pyogenes antigens and corresponding DNA fragments
09/02/2014US8821889 West Nile Virus vaccine
09/02/2014US8821885 Immunogenic compositions and methods
09/02/2014US8821851 Inflammation-inhibitory serum factors and uses thereof
09/02/2014CA2645488C Formulations comprising rapamycin and methods using same for vascular permeability-related diseases or conditions
09/02/2014CA2642952C Pharmaceutical composition comprising oseltamivir phosphate
09/02/2014CA2413866C Compositions and methods of monoclonal and polyclonal antibodies specific for t cell subpopulations
08/2014
08/28/2014WO2014130922A1 Compositions and methods for treating fungal infections
08/28/2014WO2014130810A1 C-3 alkyl and alkenyl modified betulinic acid derivatives useful in the treatment of hiv
08/28/2014WO2014130016A1 Drug combinations to treat liver cancer
08/28/2014WO2014128724A1 Antitubercular compounds and process for the preparation thereof
08/28/2014WO2014128213A1 Compounds for use in inhibiting hiv capsid assembly
08/28/2014WO2014128206A1 Compounds for use in inhibiting hiv capsid assembly
08/28/2014WO2014128198A1 Bilaterally-substituted tricyclic compounds for the treatment of human immunodeficiency virus type-1 (hiv-1) infection and other diseases
08/28/2014WO2014128189A1 2-aminopyrimidine derivatives for the treatment of viral infections
08/28/2014WO2014128057A1 Synthetic or recombinant fucosylated oligosaccarides for use in the treatment of infections
08/28/2014WO2014083060A3 Pseudomonas antigens and antigen combinations
08/28/2014US20140242106 Staphylococcus aureus proteins and nucleic acids
08/28/2014US20140242094 Methods related to tim 3, a th1-specific cell surface molecule, for activating antigen presenting cells
08/28/2014US20140242051 Probiotic, Lactic Acid-Producing Bacteria and Uses Thereof
08/27/2014EP2769973A2 Ingenane-type diterpene compound, and pharmaceutical composition for treating or preventing viral infectious diseases containing same
08/27/2014EP2769726A1 Synthetic or recombinant fucosylated Oligosaccarides for use in the treatment of infections
08/27/2014EP2769723A1 Compounds for use in inhibiting HIV capsid assembly
08/27/2014EP2769722A1 Compounds for use in inhibiting HIV capsid assembly
08/27/2014EP2769715A2 Methods for treating autoimmune disorders, and reagents related thereto
08/27/2014EP2769713A1 Solid oral composition comprising a S1P receptor agonist and a sugar alcohol
08/27/2014EP2768840A1 Anti-diabetic aminosteroid derivatives
08/27/2014EP2768838A1 Substituted 3',5'-cyclic phosphates of purine nucleotide compounds and pharmaceutical compositions for the treatment of viral infections
08/27/2014EP2768831A1 A compound for the treatment of hepatitis c
08/27/2014EP2768798A1 Novel phenicol antibacterials
08/27/2014EP2768528A1 Adjuvanted influenza b virus vaccines for pediatric priming
08/27/2014EP2768513A2 Use of avermectin derivative for increasing bioavailability and efficacy of macrocylic lactones
08/27/2014EP2768503A1 Pharmaceutical compositions comprising beta-lactam antibiotic, sulbactam and beta-lactamase inhibitor
08/26/2014US8816082 Heterocyclyl-pyridinyl-based biphosphonic acid, pharmaceutically acceptable salt thereof, composition thereof and method of use thereof
08/26/2014US8815831 Treatment of Acinetobacter with alginate oligomers and antibiotics
1 ... 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 ... 1798